Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

A man diagnosed with stage four prostate cancer after having a swollen knee says he does not know how long he has left and is ...

WHEN Kevin Hurley noticed his knee was swollen, he assumed it was just a cycling injury. The 61-year-old said the swelling ...

Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...

What began as a routine hospital visit for diabetes treatment turned into <br />a life-saving intervention for a 56-year-old businessman from Mizoram after doctors at Manipal Hospitals in Kolkata ...

Giorgia Meloni countered the proliferation of AI-generated images of her wearing lingerie by doing something unexpected: She ...

Patients with pT3N0M0 disease after radical prostatectomy for localized prostate cancer are at risk for local relapse. Immediate radiation therapy is known to improve local control and biochemical ...

Though AI hype dominates headlines, a collaboration between Norfolk Southern and Georgia Tech reveals how AI-powered inspection systems are identifying critical flaws that human inspectors and ...

Survival and fracture risk with radium-223 therapy in metastatic castrate-resistant prostate cancer (mCRPC): A real-world analysis. Real-world treatment patterns in patients with BRCA 1/2-positive ...